Platelet-activating factor induces collagenase expression in corneal epithelial cells

Area of Science:

• Ophthalmology
• Molecular Biology
• Immunology

Background:

• Platelet-activating factor (PAF) is a lipid mediator involved in inflammation and immune responses.
• PAF accumulates in tissues like the corneal epithelium following injury.
• Its precise role in post-insult cellular events remains unclear.

Purpose of the Study:

• To investigate the effect of PAF on gene expression in rabbit corneal epithelial cells.
• To elucidate the signaling pathways involved in PAF-mediated gene regulation.
• To explore the potential role of PAF in corneal wound healing and pathology.

Main Methods:

• Rabbit corneas were cultured and treated with methylcarbamoyl PAF, a nonhydrolyzable PAF analog.
• Gene expression levels of c-fos, c-jun, and collagenase type I were quantified.
• Experiments included the use of cycloheximide (protein synthesis inhibitor) and BN-50730 (PAF antagonist).

Main Results:

• PAF rapidly increased c-fos and c-jun expression within 1 hour.
• Collagenase type I gene expression was upregulated by PAF, peaking at 8 hours.
• Cycloheximide potentiated immediate-early gene induction but inhibited collagenase expression, indicating a link.
• BN-50730 blocked PAF-induced expression of immediate-early genes and collagenase type I.

Conclusions:

• PAF signaling in corneal epithelial cells upregulates genes involved in extracellular matrix remodeling.
• This suggests PAF plays a role in corneal wound healing.
• Aberrant PAF-induced collagenase production may contribute to corneal ulcer development and other inflammatory conditions.
• Inhibitors of the PAF pathway may offer therapeutic potential for related disorders.